Home/Drug Pricing and Access/Pfizer Withdraws Oxbryta from Market Due…Drug Pricing and AccessSeptember 27, 2024Pfizer Withdraws Oxbryta from Market Due to Safety ConcernsBy Richard Waithe, PharmD#Drug Discontinuations & Withdrawals#Drug Safety & Recalls#FDA ApprovalsKeep readingRelated ArticlesDrug Pricing and AccessFDA Approves First True Generic Flovent HFA for Asthma TreatmentDrug Pricing and AccessCVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost
